CDK4 and mucositis: The association between CDK4/6 inhibitors and MRONJ was suggested for the first time by Marcianò et al. Although no mechanism of action has been described, Marcianò et al. associated stomatitis/mucositis produced by CDK4/6 inhibitors with an eventual risk of developing MRONJ.